Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.4750 (0.18%) ($5.4750 - $5.4750) on Fri. Dec. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 51 | Latest Price | $5.4750(0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.6% a day on average for past five trading days. | Weekly Trend | CEMI declines -9.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) VIXM(44%) VXX(34%) OIH(2%) EWY(-6%) EDOC(10%) | Factors Impacting CEMI price | CEMI will decline at least -2.67% in a week (0% probabilities). SPY(-76%) XLK(-69%) JNK(-65%) QQQ(-63%) HYG(-56%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $5.9 | 5 Day Moving Average | $5.41(1.2%) | 10 Day Moving Average | $5.82(-5.93%) | 20 Day Moving Average | $5.9(-7.2%) | To recent high | -27.4% | To recent low | 9.5% | Market Cap | $110m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |